Skip to main content
GutCited

Berberine para Gut Dysbiosis

D

Preclinical evidence that berberine modulates microbiome composition. Limited human microbiome data.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dgut\u002Ddysbiosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

Conclusión

Preclinical evidence that berberine modulates microbiome composition. Limited human microbiome data.

Key Study Findings

Other
Design and Activity Evaluation of Berberine-Loaded Dual pH and Enzyme-Sensitive Colon-Targeting Microparticles.
Dose: None vs: Free berberine; DSS-induced UC model vs normal mice Outcome: DAI scores, inflammatory cytokines, gut microbiota Efecto: None <0.01 (DAI); <0.05 (cytokines)

Población: DSS-induced UC mouse model (male KM mice)

Other
Oxyberberine alleviates fructose-induced hyperuricemia by modulating purine metabolism and gut microbiota.
Dose: None vs: Fructose-induced HUA control Outcome: Serum uric acid levels Efecto: None None

Población: Fructose-induced hyperuricemia rats

Review
Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent.
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Other
Co-administration of berberine and evodiamine: Mitigating evodiamine-induced hepatotoxicity and potentiating colitis treatment.
Dose: None vs: EVO alone; colitis mouse model Outcome: Hepatotoxicity markers and colitis inflammation Efecto: None None

Población: C57 mice (normal and colitis models)

In Vitro 1 weeks
Phellodendron bark extract and berberine chloride suppress microbiome dysbiosis in a saliva-derived in vitro microcosm …
Dose: None vs: Untreated biofilm control Outcome: Microbiome dysbiosis suppression in biofilm Efecto: None None

Población: Saliva-derived in vitro microcosm biofilm model with P. gingivalis

Key Statistics

2

Estudios

100

Participantes

Positive

D

Calificación

Referenced Papers

Comprehensive Physiology 2021 21 citas
Alternative therapies in … 2017 9 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
500-1,500 mg/day in divided doses
siboprotocol:
500 mg two to three times daily for 4 weeks (as part of herbal antimicrobial protocol)
giantimicrobial:
500 mg twice daily

Límite superior: Generally well-tolerated up to 1,500 mg/day in divided doses

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --
None 1 weeks Positive --
None -- Mixed --
None -- Positive --

Mejor momento para tomar: With meals; divide doses throughout the day (do not take full daily dose at once)

Safety & Side Effects

Efectos secundarios reportados

  • GI side effects (diarrhea, constipation, flatulence, abdominal pain) — most common
  • May cause uterine contractions (contraindicated in pregnancy)
  • Headache
  • Skin rash (rare)

Interacciones conocidas

  • Diabetes medications (berberine significantly lowers blood sugar; risk of hypoglycemia)
  • Cyclosporine (berberine inhibits CYP3A4, increasing cyclosporine levels)
  • Anticoagulants (may have additive blood-thinning effects)
  • Metformin (additive glucose-lowering effect; monitor closely)
  • Macrolide antibiotics (berberine inhibits CYP3A4)

Ingesta máxima tolerable: Generally well-tolerated up to 1,500 mg/day in divided doses

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Berberine help with Gut Dysbiosis?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Berberine may support Gut Dysbiosis management. Our evidence grade is D (Very Early Research).
How much Berberine should I take for Gut Dysbiosis?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day in divided doses. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include GI side effects (diarrhea, constipation, flatulence, abdominal pain) — most common, May cause uterine contractions (contraindicated in pregnancy), Headache, Skin rash (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Gut Dysbiosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.